ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges

Shares of ImmuCell Corporation (ICCC) have lost 3% since the company reported earnings for the third quarter of 2024. Notably, the S&P 500 index declined 2% in the same period. Over the past month, ICCC stock has seen a 0.3% decline against the S&P 500's 0.7% rise, highlighting relatively underwhelming performance amid broader market strength.Q3 Sales & Earnings PerformanceThe company reported third-quarter 2024 earnings per diluted share of 9 cents, down from 12 cents in the prior-year quarter.ImmuCell's p ...